Wellington Management Group
ORKA

Wellington Management Group’s Oruka Therapeutics ORKA Stock Holding History

Wellington Management Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Sell
119,601
-1,624
-1% -$108K ﹤0.01% 1260
2026
Q1 		$5.95M Buy
121,225
+36,509
+43% +$1.27M ﹤0.01% 1374
2025
Q4 		$2.57M Sell
84,716
-6,378
-7% -$178K ﹤0.01% 1535
2025
Q3 		$1.75M Buy
+91,094
New +$1.35M ﹤0.01% 1665
2025
Q2 		– Sell
-87,501
Closed -$898K – 2075
2025
Q1 		$898K Sell
87,501
-7,588
-8% -$94.6K ﹤0.01% 1726
2024
Q4 		$1.84M Buy
95,089
+12,952
+16% +$316K ﹤0.01% 1585
2024
Q3 		$2.01M Buy
+82,137
New +$2.86M ﹤0.01% 1538

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Wellington Management Group's ORKA Position: Q2 2026 in Review

Wellington Management Group reduced its Oruka Therapeutics (ORKA) stake by 1.3% in Q2 2026, selling an estimated $108K and leaving 119,601 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1260.

Wellington Management Group first reported a position in ORKA in Q3 2024 and has held it in 7 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Wellington Management Group held 119,601 shares of Oruka Therapeutics worth $11.4M as of Q2 2026.
  • Wellington Management Group sold 1,624 Oruka Therapeutics shares in Q2 2026, an estimated $108K.
  • Oruka Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1260 holding.
  • Wellington Management Group first reported a position in Oruka Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.